EUVIMEDEUVIMED entdecken
Crossref

Cilostazol novel neuroprotective mechanism against rotenone-induced Parkinson's disease in rats: Correlation between Nrf2 and HMGB1/TLR4/PI3K/Akt/mTOR signaling

Rehab M El-Sayed, Ahmed M Abdelaziz, Hala F Zaki, Nora O Abdel Rasheed

International Immunopharmacology · 2023

DOI: 10.1016/j.intimp.2023.109986 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Rehab M El-Sayed und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Faculty of Pharmacy, Sinai University, El-Arish, Egypt. Hauptthemen laut MEDLINE: Parkinson Disease, HMGB1 Protein, Neuroprotective Agents. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 79 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseHMGB1 ProteinNeuroprotective AgentsRatsAnimalsProto-Oncogene Proteins c-aktRotenoneCilostazolPhosphatidylinositol 3-KinasePhosphatidylinositol 3-KinasesNF-E2-Related Factor 2Toll-Like Receptor 4NeuroprotectionTOR Serine-Threonine KinasesMammals

Stichwörter der Autor:innen

CilostazolHMGB1/TLR4Nrf2/HO-1PI3K/Akt/mTORParkinson’s diseaseRotenone

Substanzen

Proto-Oncogene Proteins c-aktRotenoneCilostazolPhosphatidylinositol 3-KinasePhosphatidylinositol 3-KinasesNF-E2-Related Factor 2HMGB1 ProteinToll-Like Receptor 4TOR Serine-Threonine KinasesNeuroprotective Agents

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Sinai University, El-Arish, Egypt.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Sinai University, El-Arish, Egypt. Electronic address: ahmed.abdelaziz@su.edu.eg.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt.

Zitieren

APA

El-Sayed, R. M., Abdelaziz, A. M., Zaki, H. F., & Abdel Rasheed, N. O. (2023). Cilostazol novel neuroprotective mechanism against rotenone-induced Parkinson's disease in rats: Correlation between Nrf2 and HMGB1/TLR4/PI3K/Akt/mTOR signaling. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.109986

Vancouver

El-Sayed RM, Abdelaziz AM, Zaki HF, Abdel Rasheed NO. Cilostazol novel neuroprotective mechanism against rotenone-induced Parkinson's disease in rats: Correlation between Nrf2 and HMGB1/TLR4/PI3K/Akt/mTOR signaling. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.109986

BibTeX
@article{ElSayed2023,
  author = {El-Sayed, Rehab M and Abdelaziz, Ahmed M and Zaki, Hala F and Abdel Rasheed, Nora O},
  title = {Cilostazol novel neuroprotective mechanism against rotenone-induced Parkinson's disease in rats: Correlation between Nrf2 and HMGB1/TLR4/PI3K/Akt/mTOR signaling},
  journal = {International Immunopharmacology},
  year = {2023},
  doi = {10.1016/j.intimp.2023.109986}
}
Kostenlos starten →